Amylyx Pharmaceuticals (AMLX) — Entry Risk Score
Stock · re-scored every trading day · data as of 2026-11-12
The entry score measures one thing: how far Amylyx Pharmaceuticals's price sits from a defensible technical level, on a 30–98 scale. High scores (79+) mean the price has pulled back into a zone where risk can be defined; low scores mean the price is extended above its own trend — not that the stock is bad, but that chasing it here carries undefined risk. The full formula is public on our methodology page.
On 2026-11-12, Amylyx Pharmaceuticals's price sits 0.70 ATR above its 20-day average ($28.74); it trades above its 200-day average ($20.72); its 14-day RSI is 54; it has moved +13.36% over 20 sessions; our regime filter classifies it as a strong uptrend.
Falling-knife flag: this Buy Zone score comes on top of a -24.71% decline over roughly 60 sessions. In our own data that pattern has swung harder than other Buy Zone names in both directions. See the audit.
Is Amylyx Pharmaceuticals (AMLX) a buy right now?
Amylyx Pharmaceuticals scores 81/98 (Buy) as of 2026-11-12; it is 24.7% below its 52-week high of $39.66; it is above its 200-day average; it moved +1.22% over the last 5 sessions. A high score means our model rates today's price as a favorable, defined-risk entry, based on where it sits versus its 20-day average after adjusting for trend and volatility. It is not a prediction that the price will rise. It also carries a falling-knife flag (down 24.71% over ~60 sessions). Not investment advice.
Score history
Every point is a recorded daily snapshot, committed publicly the evening it was scored — history can't be rewritten after the fact.
| Date | Score | Δ | Close |
|---|---|---|---|
| 2026-11-12 | 81 | -3 | $29.86 |
| 2026-11-06 | 84 | -4 | $29.50 |
| 2026-11-05 | 88 | +4 | $27.62 |
| 2026-11-04 | 84 | +0 | $29.40 |
| 2026-11-03 | 84 | -1 | $29.20 |
| 2026-11-02 | 85 | -1 | $28.04 |
| 2026-10-29 | 86 | -3 | $28.68 |
| 2026-10-28 | 89 | +1 | $28.07 |
| 2026-10-27 | 88 | -10 | $28.30 |
| 2026-10-26 | 98 | +3 | $27.09 |
| 2026-10-23 | 95 | +7 | $27.20 |
| 2026-10-22 | 88 | +2 | $28.57 |
Related stocks
See today's full rankings + entry plan for AMLX →Get the Sunday Brief
One email a week, before the open: what the board did, which calls worked, which didn't, and what changed. Free. No spam, unsubscribe anytime.